Continuous Glucose Monitoring: What's New in 2025?

This activity was originally presented during the 2025 PTCE Diabetes Day of Education on May 29, 2025.

Program Description
This session will establish the critical need for improved diabetes management, emphasizing the long-term and acute complications associated with suboptimal glycemic control and the impact on the quality of life of individuals living with diabetes. The benefits of currently available continuous glucose monitoring (CGM) devices and their practical applications in diabetes management will be discussed, as will features that differentiate them. Additionally, the crucial aspect of cost and coverage will be explored, providing participants with an update on state-specific variations in coverage policies for CGM devices to improve access.

Target Audience: Community pharmacists and pharmacy technicians

Type of Activity: Application
Release date: June 4, 2025
Expiration date: June 4, 2026
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify common diabetes-related complications and their impact on quality of life
• Explain the benefits of continuous glucose monitoring (CGM) devices in improving glycemic control and reducing the risk of diabetes-related complications and key features of prescription CGM devices
• Explore strategies to overcome clinical and administrative barriers to CGM access and utilization

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity numbers 0290-0000-25-174-H01-P and 0290-0000-25-174-H01-T. The activity is available for CE credit through June 4, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, has the following relevant financial relationships with commercial interests to disclose:

Consultant: Medtronic, Tandem
Speakers Bureau: Dexcom, Abbott, Insulet, Ascensia, Cequr, Mannkind, Novo Nordisk, Lilly, Cequr

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Robert Nichols PharmD, BCPS

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms